Answers are grounded in this paper and cite their sources.
Coronavirus disease-19 (COVID-19) pneumonia is a heterogeneous disease with variable effect on lung parenchyma, airways, and vasculature leading to long-term effects on lung functions. Although the lung is the primary target organ involvement in COVID-19, many patients were shown pulmonary and extrapulmonary manifestations of diseases variably during the first and second wave, which occurred as resultant pathophysiological effects of immune activation pathway and direct virus-induced lung damage.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: